# Halozyme Therapeutics, Inc.: Form 8-K, filed Aug 18, 2026

- Company: [Halozyme Therapeutics, Inc.](/companies/halo.md) (CIK 1159036)
- Form: 8-K
- Filed: 2026-08-18
- Accepted by EDGAR: Aug 18, 2026, 16:04 ET
- Period: 2026-08-14
- Accession: 0001159036-26-000106
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/halo-20260814.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1159036/000115903626000106/halo-20260814.htm

Filed Aug 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001159036-26-000106. Last ingested by Listed: Nov 5, 2026, 17:46 ET. No prices; not investment advice.